Inactivation rates in batch studies for four commonly used surrogate bacteriophages were measured in stable aqueous iodine solutions for the purpose of determining which was the most suited to evaluate iodine disinfection efficacy in batch and continuous flow conditions. Two types of group Leviviridae bacteriophages were used, Type I (MS2) and Type II (GA), along with group Microviridae, Phi-X174, and group Tectiviridae, PRD1. Inactivation was compared at iodine doses of 1.0-1.5 mg I 2 /l. Phi-X174 were more strongly inactivated than PRD1. The lipid component of PRD1 is thought to enhance resistance to iodine over non-lipid-containing bacteriophages by protecting easily oxidized groups on the protein capsid, but further research is needed before proving this hypothesis. The results from this research may provide a surrogate standard for more rigorous and developed research into the mode of iodine disinfection and its inactivation kinetics.
INTRODUCTION
Extensive viral inactivation research has been conducted on potable water disinfectants such as chlorine, ozone and UV, resulting in the publication of an array of defined surrogate bacteriophages and methods that can be used to model the response of pathogenic enteroviruses (Cramer et al. 1976; Alvarez & O'Brien 1982; Battigelli et al. 1993) .
However, limited research has been conducted utilizing iodine; and an adequate bacteriophage surrogate for iodine inactivation of pathogenic enteroviruses is as yet undefined. Indeed, little is known about the disinfection properties of iodine such as target sites and mode(s) of inactivation. With the emergence of point-of-use water disinfection devices containing iodinated materials (Marchin & Fina 1989) , such data for critical testing strategies are needed. Published inactivation studies have utilized iodine concentrations well above that considered palatable for human consumption and have yielded limited kinetic information on bacteriophages due to experimental concentrations that reduce phage numbers quickly below detectable ranges. This study presents an analysis of different bacteriophage groups to determine which among these groups are most suited to evaluate iodine disinfection as indicated by superior persistence in the presence of low doses of free iodine. Gerba (University of Arizona) were produced in the same manner as MS2 and GA with the exception of the hosts used for growth: C-13 (ATCC 13706) and a strain of Salmonella typhimurium obtained from the laboratories of C. P. Gerba (University of Arizona), respectively. To prepare cleaner stocks for disinfection experiments, crude stocks of MS2, GA and Phi-X174 were pelleted by ultracentrifugation at 90,000 g for 4 h (Battigelli et al. 1993) .
The pellet was then resuspended in sterile borate buffer (pH 7) up to 1 ml and placed at 4°C for no longer than 1 day before usage in disinfection experiments. PRD1 crude stock was pelleted at 90,000 g for 2 h in a Beckman SW41Ti rotor and then resuspended in borate buffer and used the same day.
Iodine analysis
The Hach DPD colorimetric method for iodine analysis was used to determine iodine residuals as mg I 2 /l by spectrophotometry (Hach, Loveland, CO).
Iodine inactivation experiments
All batch inactivation experiments were conducted at 10°C in 0.05 molar borate buffer (pH 5.6) made with halogen demand free water (HDFW). The selected pH ensured that the most stable iodine residual, I 2 , would be predominant. The borate buffer is known to slow the rate of active iodine residual decomposition (Brion & Silverstein 1999) . Ultracentrifuged stocks containing a mixture of phages were diluted in borate buffer to the desired concentrations and combined as either pooled Stock A (MS2 + PRD1) or pooled Stock B (Phi-X174 + PRD1) for use in replicate inactivation experiments. A stock iodine solution (resublimed I 2 crystals and halogen demand free water (HDFW)) was diluted with borate buffer to 1.4 mg I 2 /l and dispensed in 27 ml amounts into four 50 ml polypropylene centrifuge tubes.
This initial iodine concentration would decrease to near 1.0 mg/l upon the addition of the phage-containing stock.
Three tubes containing iodinated buffer had 3 ml of combined phage stock added and were then used to measure phage concentration (1), pH (2) and iodine residual (3) throughout the experiment. Aliquots from tube 1 were taken at 1, 5, 10, 30 and 60 min and immediately diluted in PBS containing 1% Na 2 SO 3 to quench the reaction.
Solution pH and residual concentrations were measured at 0, 30 and 60 min. In the fourth tube (4), containing 27 ml of iodinated buffer and 3 ml of non-iodinated buffer, measurements were taken at 0 and 60 min to check for halogen demand of the buffer and containers. Phage controls were taken at the beginning and end of the experiments from a fifth tube (5) that contained non-iodinated borate buffer and phage spike solution. The GA inactivation experiments were done in a similar manner, with two major differences: only GA phage stock was used instead of a stock containing a combination of bacteriophages and the initial iodine titer was increased to 2.1 mg/l iodine which resulted in an initial iodine concentration of 1.5 mg/l after the addition of the GA phage stock.
Iodinated resin studies
A commercial grade of pentaiodide quaternary ammonium strong base resin was obtained commercially (PentaPure, Eagan, MN) to see if the behavior of the selected phage groups would be similar in a kinetic study that used both bound and free forms of iodine. The resin (2.5 cm 3 ) was packed in a 3.0 cm 3 plastic syringe barrel (Promega, Madison, WI) fitted with a fiber glass plug.
Suspensions of phages in HDFW at 25°C were pumped through the resin bed at a flow rate of 10 ml/min using a peristaltic pump (Masterflex, Cole-Palmer). An initial sample without phages was collected to determine free iodine concentration as described above. Phage samples were collected in 1% Na 2 SO 3 to quickly neutralize the iodine residual upon passage through the resin column.
Surviving phages were titered as described below.
Sample assay
Phage concentrations at sample times were determined by plaque formation on double-layer agar assay as previously described (Brion & Silverstein 1999) with triplicate plating of each dilution. Detection limit was calculated to be 30 PFU/ml in the iodine inactivation tube 1.
RESULTS AND DISCUSSION
The difference in susceptibility of each bacteriophage group to iodine residuals is clearly illustrated by the rate at (Table 1 ). The slight difference in inactivation for PRD1 between experiments using Stock A and B is thought to be due to slight differences in the overall halogen demand of the pooled stocks. It is of note that, in subsequent single phage stock experiments with GA at higher iodine residuals (1.5 versus 1.0), that GA phage type showed removal similar to PRD1. As can be seen in Table 1 , the average inactivation of PRD1 and GA at 10 and 30 min is quite close, even though the GA experiment had higher iodine residual. In Figure 1 Figure 1 and Table 1 . Other studies have shown GA to exhibit superior survival to inactivation in surface waters when compared to MS2 (Brion et al. 2002) and our batch study with iodine is in agreement with these previous results.
From the results above, MS2 is not the hardiest of the phage groups tested, and when reviewing other studies, it would not appear to be as resistant against iodine inactivation at pH values below 7 as enteric viruses such as poliovirus, echovirus and hepatitis A virus. A previous study by Sobsey et al. (1991) has shown animal viruses to be resistant to larger doses (8 mg/l versus 1.0-1.5 mg/l) of iodine than were used in this study with MS2. They found poliovirus type 1 and echovirus type 1 to have inactivation times of < 3.9 and < 4.9 min to drop 99.99% of the initial concentration (log C/C 0 = − 4) at pH 7.0, iodine dose = 8 mg/l and temperature = 25°C (Sobsey et al. 1991) .
As pH decreased to 4.5 (temperature and iodine dose remained the same), the times for 99.99% inactivation increased to 7.2, 54 and < 13 min for hepatitis A virus, poliovirus type 1 and echovirus type, respectively (Sobsey et al. 1991) . In our study, MS2 declined more than 99.99% However, there are more factors to consider when selecting a good phage surrogate for enteric viruses to test disinfection processes than similar disinfection kinetics; one should consider similar structure as well. PRD1, although a hardier phage than MS2, is not similar enough in structure to the naked human enteric viruses and therefore will not behave similarly due to capsid protection provided by its lipid component. However, the more similarly structured F + ssRNA coliphage GA may be more appropriate to use based on its similar structural and iodine survival characteristics similar to those reported for poliovirus type 1. Our results show that GA coliphages drop 90% in titer at iodine levels of 1.5 mg/l as I 2 at Alvarez & O'Brien (1982) for poliovirus at 2 min, pH = 6.0, temperature = 25°C, iodine dose = 2.5 mg/l as I 2 . It would appear that, of the F + ssRNA phages, which are similar in structure to enteric viruses of public health concern, the GA type would be a better surrogate of animal viruses than MS2 in batch experiments.
Continuous flow experiments through iodinated resin columns were conducted to determine if the survival trends would be similar to those noted in the previously discussed batch experiments. In continuous flow experiments ( Table 2) When conducting disinfectant studies it is important to understand the behavior of the halogen in the buffered water matrix with and without viruses (Table 3) . In this way, the experimental system can be modified to maintain the most stable disinfectant residual for the length of time required with minimal residual losses. As noted in prior studies by Brion & Silverstein (1999) borate buffers maintain a slower rate of hypoiodous acid (HOI) decomposition to iodate and iodide, while pH selection to as the predominant iodine disinfectant species and low halogen demand of the ultrapurified bacteriophage stocks prepared. Another study (Sobsey et al. 1991) 
